MARKET

SNN

SNN

Smith & Nephew
NYSE
23.88
-0.69
-2.81%
After Hours: 23.88 +0.01 +0.02% 16:00 04/25 EDT
OPEN
24.36
PREV CLOSE
24.57
HIGH
24.38
LOW
23.86
VOLUME
1.17M
TURNOVER
0
52 WEEK HIGH
33.09
52 WEEK LOW
21.13
MARKET CAP
10.44B
P/E (TTM)
39.63
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SNN last week (0415-0419)?
Weekly Report · 3d ago
ClearBridge International Value Strategy Q1 2024 Portfolio Manager Commentary
Seeking Alpha · 04/18 16:10
Smith+Nephew Announces New Evidence Supporting Allevyn Life Foam Dressing's Role In Pressure Injury Prevention
Benzinga · 04/18 11:12
Weekly Report: what happened at SNN last week (0408-0412)?
Weekly Report · 04/15 09:04
U.K. Top 40 Quality Dividend Stocks: Q2 2024
John Kingham has updated the list of the top 40 UK dividend stocks. The list ranks stocks based on their market cap and dividend yield alone. He is looking for quality dividend stocks with long track records of progressive dividend growth. The top 40 list now only includes stocks from the FTSE All-Share and AIM UK 50 indices.
Seeking Alpha · 04/12 17:30
Oakmark International Fund: First Calendar Quarter 2024 Commentary
The Oakmark International Fund returned 0.11% for the quarter ended March 31, compared to the benchmark, the MSCI World ex USA Index. Daimler Truck Holding was a top contributor during the quarter. Bayer is a top detractor during the same period.
Seeking Alpha · 04/10 08:00
JPMorgan’s top European picks
JPMorgan analysts published their list of top European stocks. Financials, utilities, and energy had the best 2024 dividend yield so far this year. The sectors that have better performed year-to-date are auto and parts, banks, and technology. The ones that have performed worst are utilities, real estate, and basic resources.
Seeking Alpha · 04/09 16:55
SMITH+NEPHEW SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT TO PROVIDE UNIQUE NAVBIT SPRINT™ SOLUTION IN AUSTRALIA
Reuters · 04/08 22:00
More
About SNN
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Webull offers Smith & Nephew plc (ADR) stock information, including NYSE: SNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNN stock methods without spending real money on the virtual paper trading platform.